Dyno Therapeutics
dynotx.comLocations
Cambridge, MA, USA · Cambridge, MA, USA
industry
Biotechnology · Data and Analytics · DeepTech · Health · Software
Size
51-200 employees
Stage
Series A
founded in
2018
Dyno Therapeutics is pioneering an artificial intelligence (AI) powered approach to gene therapy. Using machine learning and quantitative high-throughput in vivo experimentation, we are inventing new ways to design gene vectors with a focus on cell-targeting capsid proteins from adeno-associated virus (AAV), the most widely-used vector for gene therapies.
Something looks off?Open jobs at Dyno Therapeutics
On-site & Remote